In recent years the stem cell science has increasingly focused on mitigating the loss of vision through Ophthalmology. Cell based therapies are showing tremendous promise in mitigating many acquired and hereditary vision problems. Age Related Macular Degeneration in particular is under scrutiny as a condition that is likely to respond to adult mesenchymal cell therapy.

The deployment protocol performed under local anesthesia is all done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately 3 hours.